Alessandra Feoli

Tau-Centric Multitarget Approach for Alzheimer’s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors

Annachiara Gandini, Manuela Bartolini, Daniele Tedesco et al. · Journal of Medicinal Chemistry · 2018 · 103 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer

Maria Proto, Donatella Fiore, Chiara Piscopo et al. · Scientific Reports · 2017 · 64 citations · Full text

Medicine, Oncology, Pharmacology +17

Discovery of a Novel Chemotype of Histone Lysine Methyltransferase EHMT1/2 (GLP/G9a) Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Co-crystal Structure

Ciro Milite, Alessandra Feoli, J.R. Horton et al. · Journal of Medicinal Chemistry · 2019 · 59 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

A Novel Cell-Permeable, Selective, and Noncompetitive Inhibitor of KAT3 Histone Acetyltransferases from a Combined Molecular Pruning/Classical Isosterism Approach

Ciro Milite, Alessandra Feoli, Kazuki Sasaki et al. · Journal of Medicinal Chemistry · 2015 · 55 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies

Ciro Milite, Giorgio Amendola, Alessio Nocentini et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2019 · 40 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17